Literature DB >> 24724793

Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.

A N Ilinskaya1, M A Dobrovolskaia.   

Abstract

Nanoparticle interactions with various components of the immune system are determined by their physicochemical properties such as size, charge, hydrophobicity and shape. Nanoparticles can be engineered to either specifically target the immune system or to avoid immune recognition. Nevertheless, identifying their unintended impacts on the immune system and understanding the mechanisms of such accidental effects are essential for establishing a nanoparticle's safety profile. While immunostimulatory properties have been reviewed before, little attention in the literature has been given to immunosuppressive and anti-inflammatory properties. The purpose of this review is to fill this gap. We will discuss intended immunosuppression achieved by either nanoparticle engineering, or the use of nanoparticles to carry immunosuppressive or anti-inflammatory drugs. We will also review unintended immunosuppressive properties of nanoparticles per se and consider how such properties could be either beneficial or adverse.
© 2014 The British Pharmacological Society.

Keywords:  anti-inflammatory properties; immune inhibition; immune system; immunosuppression; inflammation; nanoparticles

Mesh:

Substances:

Year:  2014        PMID: 24724793      PMCID: PMC4243973          DOI: 10.1111/bph.12722

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  134 in total

Review 1.  Interaction of nanoparticles with immunocompetent cells: nanosafety considerations.

Authors:  Diana Boraschi; Luca Costantino; Paola Italiani
Journal:  Nanomedicine (Lond)       Date:  2012-01       Impact factor: 5.307

2.  Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Timothy M Potter; Jamie C Rodriguez; Jennifer B Hall; Scott E McNeil
Journal:  Nanomedicine (Lond)       Date:  2011-09-30       Impact factor: 5.307

3.  Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis.

Authors:  Tsutomu Sakai; Tsutomu Ishihara; Megumu Higaki; Goichi Akiyama; Hiroshi Tsuneoka
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-18       Impact factor: 4.799

4.  Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.

Authors:  Parag Kolhe; Ekta Misra; Rangaramanujam M Kannan; Sujatha Kannan; Mary Lieh-Lai
Journal:  Int J Pharm       Date:  2003-06-18       Impact factor: 5.875

5.  Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model.

Authors:  M Erdogan; J R Wright; V C McAlister
Journal:  Br J Dermatol       Date:  2002-06       Impact factor: 9.302

Review 6.  Immunoregulatory functions of mTOR inhibition.

Authors:  Angus W Thomson; Hēth R Turnquist; Giorgio Raimondi
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

7.  A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.

Authors:  Mihir Shah; Maria C Edman; Srikanth R Janga; Pu Shi; Jugal Dhandhukia; Siyu Liu; Stan G Louie; Kathleen Rodgers; J Andrew Mackay; Sarah F Hamm-Alvarez
Journal:  J Control Release       Date:  2013-07-25       Impact factor: 9.776

8.  Anti-inflammatory properties of cerium oxide nanoparticles.

Authors:  Suzanne M Hirst; Ajay S Karakoti; Ron D Tyler; Nammalwar Sriranganathan; Sudipta Seal; Christopher M Reilly
Journal:  Small       Date:  2009-12       Impact factor: 13.281

9.  Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy.

Authors:  Ha Na Woo; Hye Kyung Chung; Eun Jin Ju; Joohee Jung; Hye-Won Kang; Sa-Won Lee; Min-Hyo Seo; Jin Seong Lee; Jung Shin Lee; Heon Joo Park; Si Yeol Song; Seong-Yun Jeong; Eun Kyung Choi
Journal:  Int J Nanomedicine       Date:  2012-04-27

10.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more
  24 in total

1.  Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate.

Authors:  Robin Rajan; Manoj K Sabnani; Vikram Mavinkurve; Hilary Shmeeda; Hossein Mansouri; Sandrine Bonkoungou; Alexander D Le; Laurence M Wood; Alberto A Gabizon; Ninh M La-Beck
Journal:  J Control Release       Date:  2017-12-23       Impact factor: 9.776

Review 2.  Nanoparticles and direct immunosuppression.

Authors:  Terrika A Ngobili; Michael A Daniele
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

3.  Immune responses to engineered nanomaterials: current understanding and challenges.

Authors:  Nasser B Alsaleh; Jared M Brown
Journal:  Curr Opin Toxicol       Date:  2017-11-24

Review 4.  Tissue Engineering Approaches to Modulate the Inflammatory Milieu following Spinal Cord Injury.

Authors:  Courtney M Dumont; Daniel J Margul; Lonnie D Shea
Journal:  Cells Tissues Organs       Date:  2016-10-05       Impact factor: 2.481

Review 5.  Nanomaterials, inflammation, and tissue engineering.

Authors:  Jagannath Padmanabhan; Themis R Kyriakides
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-11-25

Review 6.  Tolerogenic Nanoparticles to Treat Islet Autoimmunity.

Authors:  Tobias Neef; Stephen D Miller
Journal:  Curr Diab Rep       Date:  2017-08-08       Impact factor: 4.810

Review 7.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

Review 8.  Controlled release strategies for modulating immune responses to promote tissue regeneration.

Authors:  Courtney M Dumont; Jonghyuck Park; Lonnie D Shea
Journal:  J Control Release       Date:  2015-08-08       Impact factor: 9.776

Review 9.  Immunomodulatory Nanosystems.

Authors:  Xiangru Feng; Weiguo Xu; Zhongmin Li; Wantong Song; Jianxun Ding; Xuesi Chen
Journal:  Adv Sci (Weinh)       Date:  2019-06-21       Impact factor: 16.806

Review 10.  Effects of engineered nanoparticles on the innate immune system.

Authors:  Yuanchang Liu; Joseph Hardie; Xianzhi Zhang; Vincent M Rotello
Journal:  Semin Immunol       Date:  2017-10-04       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.